LEI: 549300Q7EXQQH6KF7Z84

16 May 2025

RTW Biotech Opportunities Ltd
(the "Company")

Notice of Annual General Meeting

RTW Biotech Opportunities Ltd announces that its Annual General Meeting ("AGM") will be held at 1^st Floor Royal Chambers, St Julian's Avenue St Peter Port, Guernsey on 9 June 2025 at 2pm BST. The Notice of AGM was dispatched to all shareholders on 15 May 2025.

A copy of the Notice of AGM has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism The Notice of AGM may also be viewed on the Company's website at www.rtwfunds.com/rtw-biotech-opportunities-ltd

The Annual Report and Audited Financial Statements for the year ended 31 December 2024 (the "Annual Report") is also available on the Company's website at www.rtwfunds.com/rtw-biotech-opportunities-ltd

You will not have received a hard copy proxy form for the AGM in the post. You can instead submit your proxy vote electronically via the Investor Centre app or by accessing the web browser at https://uk.investorcentre.mpms.mufg.com/. Full details of how to vote are set out in the Notes to the Notice of Meeting. Please submit your proxy vote so as to reach the Company's registrar as soon as possible and in any event no later than 2pm BST on 5 June 2025 or, if you are a CREST member, by using the service provided by Euroclear. Shares held on your behalf by a broker or nominee must be voted by the broker, per your instructions, and cannot be voted at https://uk.investorcentre.mpms.mufg.com/. The completion of the form of proxy will not preclude a member from attending and voting in person at the meeting if it is so allowed.

If any shareholder has questions related to the business of the AGM, please submit your queries to biotechopportunities@rtwfunds.com by 2pm BST on 5 June 2025.

Enquiries:

About RTW Biotech Opportunities Ltd:

RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Biotech Opportunities Ltd invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives. RTW Biotech Opportunities Ltd is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.

Visit the website at www.rtwfunds.com/rtw-biotech-opportunities-ltd for more information.

***********

The information in this announcement may include forward-looking statements, which are based on the current expectations and projections about future events, and in certain cases can be identified by the use of terms such as "may", "will", "should", "expect", "anticipate", "project", "estimate", "intend", "continue", "target", "believe" (or the negatives thereon) or other variations thereon or comparable terminology. These forward-looking statements, as well as those included in any related materials, are subject to risks, uncertainties and assumptions about the Company and/or its underlying investments, including, among other things, the development of the applicable entity's business, trends in its operating industry, expected use of financing proceeds and future capital expenditures and acquisitions. In light of these risks, uncertainties and assumptions, the events in the forward-looking statements may not occur.

The information contained in this announcement is given at the date of its publication (unless otherwise marked). No reliance may be placed for any purpose whatsoever on the information or opinions contained in this announcement or on its completeness, accuracy or fairness.

***********